NCT07517653 2026-04-08Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal MelanomaShanghai Zhongshan HospitalPhase 2 Not yet recruiting70 enrolled
NCT05106023 2023-06-07To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced MelanomaFudan UniversityPhase 2 Unknown31 enrolled